Dr. Wei Wang, MD

Dr. Wang practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Wang's NPI, 1447570338, was assigned on June 2, 2010. Dr. Wang holds Texas license Q8383.

Dr. Wang's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Wang's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Wang is licensed in Texas.

CMS data shows 1,671 Medicare services from Dr. Wang across 14 procedure codes in 2024, for 554 Medicare patients. Medicare paid $56,124 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 554 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 273 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 66, with 43% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Dr. Wang from 5 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 92% of the total. Janssen Research & Development, LLC paid the most, $3,700.